Charles Schwab
SKIN icon

Charles Schwab’s SkinHealth Systems SKIN Stock Holding History

Charles Schwab’s Portfolio SKIN Stock Details SKIN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$284K Sell
410,382
-315,627
-43% -$241K ﹤0.01% 3338
2026
Q1 		$646K Sell
726,009
-36,047
-5% -$44.3K ﹤0.01% 3028
2025
Q4 		$1.06M Sell
762,056
-44,814
-6% -$64.8K ﹤0.01% 2906
2025
Q3 		$1.61M Buy
806,870
+27,927
+4% +$56.7K ﹤0.01% 2805
2025
Q2 		$1.49M Buy
778,943
+108,373
+16% +$153K ﹤0.01% 2767
2025
Q1 		$899K Sell
670,570
-17,795
-3% -$27.1K ﹤0.01% 2876
2024
Q4 		$1.09M Buy
688,365
+45,525
+7% +$71.5K ﹤0.01% 2882
2024
Q3 		$926K Buy
642,840
+31,522
+5% +$51.7K ﹤0.01% 2939
2024
Q2 		$1.17M Sell
611,318
-36,383
-6% -$102K ﹤0.01% 2865
2024
Q1 		$2.88M Buy
647,701
+47,005
+8% +$153K ﹤0.01% 2484
2023
Q4 		$1.87M Sell
600,696
-42,326
-7% -$159K ﹤0.01% 2642
2023
Q3 		$3.87M Sell
643,022
-26,064
-4% -$183K ﹤0.01% 2366
2023
Q2 		$5.6M Sell
669,086
-5,938
-0.9% -$61.7K ﹤0.01% 2200
2023
Q1 		$8.53M Sell
675,024
-61,885
-8% -$716K ﹤0.01% 1945
2022
Q4 		$6.71M Sell
736,909
-18,780
-2% -$203K ﹤0.01% 2056
2022
Q3 		$8.91M Buy
755,689
+65,122
+9% +$823K ﹤0.01% 1912
2022
Q2 		$8.88M Buy
690,567
+12,825
+2% +$172K ﹤0.01% 1904
2022
Q1 		$11.4M Buy
677,742
+21,963
+3% +$362K ﹤0.01% 1881
2021
Q4 		$15.8M Buy
655,779
+56,004
+9% +$1.44M ﹤0.01% 1751
2021
Q3 		$15.6M Buy
599,775
+118,500
+25% +$2.61M 0.01% 1762
2021
Q2 		$8.09M Buy
+481,275
New +$6.58M ﹤0.01% 2111

Other funds holding SKIN

CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.1B AUM 20.71% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Charles Schwab's SKIN Position: Q2 2026 in Review

Charles Schwab reduced its SkinHealth Systems (SKIN) stake by 43% in Q2 2026, selling an estimated $241K and leaving 410,382 shares worth $284K. The position accounts for ﹤0.01% of the portfolio, ranked #3338.

Charles Schwab first reported a position in SKIN in Q2 2021 and has held it in 21 quarters since. The position peaked at $15.8M in Q4 2021. 96 funds tracked by Wall St. Rank hold SKIN as of Q2 2026.

  • Charles Schwab held 410,382 shares of SkinHealth Systems worth $284K as of Q2 2026.
  • Charles Schwab sold 315,627 SkinHealth Systems shares in Q2 2026, an estimated $241K.
  • SkinHealth Systems made up ﹤0.01% of Charles Schwab's portfolio in Q2 2026, its #3338 holding.
  • Charles Schwab first reported a position in SkinHealth Systems in Q2 2021 and has held it in 21 quarters since.
  • Charles Schwab's SkinHealth Systems position peaked at $15.8M in Q4 2021.
  • 96 funds tracked by Wall St. Rank held SkinHealth Systems as of Q2 2026.

Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.